Literature DB >> 33637483

Inhibitory CD161 Receptor Is Expressed on Glioma-Infiltrating T Cells.

.   

Abstract

In glioma, tumor-infiltrating cytotoxic T cells expressed the inhibitory NK-cell receptor CD161. ©2021 American Association for Cancer Research.

Entities:  

Year:  2021        PMID： 33637483     DOI： 10.1158/2159-8290.CD-RW2021-027

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  4 in total

1.  Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.

Authors:  Yanhua Mou; Lu Zhang; Zhantao Liu; Xiujun Song
Journal:  BMC Cancer       Date:  2022-02-28       Impact factor: 4.430

2.  Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.

Authors:  Wang Di; Wenhua Fan; Fan Wu; Zhongfang Shi; Zhiliang Wang; Mingchen Yu; You Zhai; Yuanhao Chang; Changqing Pan; Guanzhang Li; Ulf Dietrich Kahlert; Wei Zhang
Journal:  Cancer Sci       Date:  2021-12-24       Impact factor: 6.716

3.  Identification of CD161 expression as a novel prognostic biomarker in breast cancer correlated with immune infiltration.

Authors:  Miaomiao Weng; Hui Xie; Mingjie Zheng; Xinwen Hou; Shui Wang; Yue Huang
Journal:  Front Genet       Date:  2022-09-30       Impact factor: 4.772

4.  A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.

Authors:  Xiaohan Zhou; Jun Du; Chengdong Liu; Hanyi Zeng; Yuting Chen; Li Liu; Dehua Wu
Journal:  Front Immunol       Date:  2021-07-09       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.